Sumifilam

N/A

Report date: 2026/05/11 20:01:57
NME

Base Information

Drug NameSumifilam
Drug Alias NameSimufilamSimufilam hydrochlorideFILORAPTI-125C0105 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFilamin-A modulators
TargetsFilamin-A
Therapy Area/IndicationsAlzheimer DiseaseHepatic Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPuerto Rico +[5] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesCassava Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCassava Sciences Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseHepatic Insufficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A